
Dr. Nitin Singhal is a highly experienced onco-surgeon in Ahmedabad, specializing in the treatment of uterus cancer (endometrial cancer) and other gynecological malignancies.
With more than 15 years of expertise in surgical oncology, he is known for his precision in robotic and minimally invasive surgeries, HIPEC expertise, and patient-focused care, helping women receive personalised treatment based on their cancer and individual needs.
Uterus cancer, often called endometrial cancer, begins in the lining of the uterus, known as the endometrium. The uterus is the hollow reproductive organ where fetal development occurs during pregnancy.
Uterine cancer is one of the common gynecological cancers affecting women and is particularly important to evaluate in women after menopause.
Important risk factors can include obesity, hormonal imbalances, diabetes, family history of cancers, and prolonged estrogen exposure.
Common warning signs may include abnormal vaginal bleeding, pelvic pain, and watery or blood-stained vaginal discharge. Because symptoms can sometimes be overlooked, timely evaluation is important when abnormal bleeding or other persistent symptoms occur.
Treatment is planned according to the stage and characteristics of the cancer, as well as the patient's overall health and, in selected younger women, fertility goals.
Uterine cancer may produce symptoms that should be evaluated, particularly abnormal vaginal bleeding or bleeding after menopause.
Abnormal vaginal bleeding, particularly bleeding after menopause, should not be ignored.
While these symptoms can occur due to conditions other than cancer, a gynecological evaluation can help identify the underlying cause.
Early assessment can help identify uterine cancer at a stage when treatment options may be broader.
Several factors may increase the risk of developing uterine or endometrial cancer.
Excess body weight is associated with increased estrogen exposure and can increase the risk of endometrial cancer.
Conditions associated with prolonged or unbalanced estrogen exposure can contribute to endometrial cancer risk.
Diabetes is among the health factors associated with an increased risk of uterine cancer.
A family history of certain cancers may increase individual risk and may warrant discussion with a medical specialist.
Long-term exposure to estrogen without adequate progesterone balance can be associated with increased endometrial cancer risk.
Uterine cancer is particularly important to evaluate in women after menopause, especially when abnormal bleeding occurs.
Dr. Nitin Singhal provides comprehensive uterus cancer treatment in Ahmedabad, with treatment planned according to the cancer's stage, extent, and individual patient requirements.
Hysterectomy, the surgical removal of the uterus, is a standard treatment for many uterine cancers. Depending on the disease, additional surgery may be required to assess or remove affected lymph nodes.
The stage of uterine cancer helps determine how far the cancer has spread and guides treatment planning.
At this early stage, cancer is confined to the uterus, primarily involving the endometrium and, in some cases, extending into the muscle wall of the uterus. Symptoms may include abnormal vaginal bleeding or watery discharge. Treatment commonly involves hysterectomy, while carefully selected young women with early disease may be evaluated for fertility- preserving hormonal treatment.
At Stage II, the cancer has extended from the uterus into the cervix but has not spread outside the uterus. Patients may experience pelvic pain or abnormal or heavy bleeding. Treatment may involve hysterectomy with appropriate lymph node assessment, with radiation or chemotherapy considered according to the cancer's risk characteristics.
Stage III disease has extended beyond the uterus into nearby reproductive or pelvic structures and/or regional lymph nodes. Symptoms can become more noticeable and may include pelvic discomfort, abdominal symptoms, or urinary and bowel problems. Treatment generally requires a multidisciplinary approach that may combine surgery, chemotherapy, and radiation therapy.
Stage IV is the most advanced stage, where cancer may involve the bladder or rectum or spread to distant organs such as the lungs, liver, or bones. Treatment focuses on controlling the disease and may include systemic chemotherapy, targeted therapy, immunotherapy, radiation, and selected advanced surgical approaches such as HIPEC when appropriate.
Because the uterus is essential for carrying a pregnancy, standard treatment involving hysterectomy affects future fertility.
However, selected young women with carefully evaluated early-stage uterine cancer may be considered for fertility-preserving hormonal treatment. This approach is not suitable for every patient and requires specialist assessment, careful selection, and close follow-up.
Dr. Nitin Singhal is experienced in robotic and minimally invasive surgical techniques for gynecological cancers.
When appropriate for the individual cancer and surgical procedure, robotic surgery can provide precise surgical access through minimally invasive techniques.
Common questions about symptoms, risk factors, fertility, robotic surgery, and treatment.
The most common warning sign is abnormal vaginal bleeding, particularly bleeding after menopause. Other symptoms can include pelvic pain, pain during intercourse, and watery or blood-stained vaginal discharge.
Risk can be higher in women with factors such as obesity, diabetes, hormonal imbalance, prolonged estrogen exposure, certain family histories of cancer, and increasing age, particularly after menopause.
Yes. Standard treatment often involves hysterectomy, which removes the uterus and therefore affects the ability to carry a pregnancy. However, carefully selected young women with early-stage disease may be evaluated for fertility-preserving hormonal treatment.
Robotic-assisted surgery can provide a minimally invasive approach for appropriate gynecological cancer procedures. Potential advantages include precise surgical control, smaller incisions, and recovery benefits. Whether robotic surgery is appropriate depends on the patient's cancer, stage, overall health, and required procedure.
Uterus cancer is often highly treatable when detected early. Treatment may involve surgery, radiation therapy, chemotherapy, or other therapies depending on the stage and characteristics of the cancer. Advanced or recurrent disease may require a combination of systemic and specialised treatments.
Hysterectomy, which involves removal of the uterus, is a standard surgical treatment for many uterine cancers. Depending on the cancer's stage and spread, lymph node assessment or additional procedures may also be required.
HIPEC is not required for every uterine cancer. It may be considered in selected advanced cases involving spread within the abdominal cavity. The suitability of HIPEC depends on the extent and characteristics of the disease and requires specialist assessment.
Uterine cancer can recur in some patients, depending on the original stage, grade, tumour characteristics, and treatment response. Regular follow-up after treatment is important so that any concerning symptoms or signs of recurrence can be evaluated promptly.
If you have abnormal vaginal bleeding, bleeding after menopause, persistent pelvic symptoms, or have already been diagnosed with uterine cancer, consult an experienced surgical oncologist for appropriate evaluation and personalised treatment planning.
Dr. Nitin Singhal has been recognised for his contribution to cancer care and surgical oncology, reflecting his commitment to advanced surgical techniques, clinical excellence and patient-centred care.
Surgical oncology training from Tata Memorial Hospital, Mumbai.
Expertise across complex and multidisciplinary cancer surgery.
Honoured for excellence in healthcare and surgical oncology.
Focus on evidence-based and personalised cancer treatment.
Recognition that reflects a continued commitment to excellence in cancer care.